Last reviewed · How we verify
Inert Ingredients Oral Product
Inert Ingredients Oral Product is a Small molecule drug developed by Xenon Pharmaceuticals Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | Inert Ingredients Oral Product |
|---|---|
| Sponsor | Xenon Pharmaceuticals Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness (NA)
- TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders (PHASE3)
- Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance (NA)
- I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis (NA)
- NAC for Treatment-Resistant OCD and Other Related Disorders (PHASE4)
- Mitigating the Pro-inflammatory Phenotype of Obesity (PHASE1)
- Preemptive Analgesia With Celecoxib for Acute Dental Pain Management (PHASE4)
- Oral Supplementation With AM3, Hesperidin and Spermidine Supplementation on Immunity Response and Biological Age. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inert Ingredients Oral Product CI brief — competitive landscape report
- Inert Ingredients Oral Product updates RSS · CI watch RSS
- Xenon Pharmaceuticals Inc. portfolio CI
Frequently asked questions about Inert Ingredients Oral Product
What is Inert Ingredients Oral Product?
Inert Ingredients Oral Product is a Small molecule drug developed by Xenon Pharmaceuticals Inc..
Who makes Inert Ingredients Oral Product?
Inert Ingredients Oral Product is developed by Xenon Pharmaceuticals Inc. (see full Xenon Pharmaceuticals Inc. pipeline at /company/xenon-pharmaceuticals-inc).
What development phase is Inert Ingredients Oral Product in?
Inert Ingredients Oral Product is in Phase 1.